These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10488713)

  • 1. Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors.
    Monte MJ; Dominguez S; Palomero MF; Macias RI; Marin JJ
    J Hepatol; 1999 Sep; 31(3):521-8. PubMed ID: 10488713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2).
    Macias RI; El-Mir MY; Monte MJ; Serrano MA; Garcia MJ; Marin JJ
    J Control Release; 1999 Feb; 57(2):161-9. PubMed ID: 9971896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2.
    Marin JJ; Macias RI; Criado JJ; Bueno A; Monte MJ; Serrano MA
    Int J Cancer; 1998 Oct; 78(3):346-52. PubMed ID: 9766570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and biotransformation of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver.
    Macias RI; Monte MJ; El-Mir MY; Villanueva GR; Marin JJ
    J Lipid Res; 1998 Sep; 39(9):1792-8. PubMed ID: 9741691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.
    Briz O; Serrano MA; Rebollo N; Hagenbuch B; Meier PJ; Koepsell H; Marin JJ
    Mol Pharmacol; 2002 Apr; 61(4):853-60. PubMed ID: 11901224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum (II).
    Marin JJ; Herrera MC; Palomero MF; Macias RI; Monte MJ; El-Mir MY; Villanueva GR
    J Hepatol; 1998 Mar; 28(3):417-25. PubMed ID: 9551679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity.
    Larena MG; Martinez-Diez MC; Monte MJ; Dominguez MF; Pascual MJ; Marin JJ
    J Drug Target; 2001 Jun; 9(3):185-200. PubMed ID: 11697204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between tumor cell load and sensitivity to the cytostatic effect of two novel platinum-bile acid complexes, Bamet-D3 and Bamet-UD2.
    Larena MG; Martinez-Diez MC; Macias RI; Dominguez MF; Serrano MA; Marin JJ
    J Drug Target; 2002 Aug; 10(5):397-404. PubMed ID: 12442810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid.
    Pascual MJ; Macias RI; Garcia-Del-Pozo J; Serrano MA; Marin JJ
    Anticancer Res; 2001; 21(4A):2703-7. PubMed ID: 11724343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors.
    Briz O; Macias RI; Vallejo M; Silva A; Serrano MA; Marin JJ
    Mol Pharmacol; 2003 Mar; 63(3):742-50. PubMed ID: 12606785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
    Herrera MC; Palomero MF; Macias RI; Serrano MA; Marin JJ
    Anticancer Res; 1998; 18(5A):3555-63. PubMed ID: 9858939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate.
    Criado JJ; Macias RI; Medarde M; Monte MJ; Serrano MA; Marin JJ
    Bioconjug Chem; 1997; 8(4):453-8. PubMed ID: 9258440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between DNA-reactivity and cytostatic effect of two novel bile acid-platinum derivatives, Bamet-UD2 and Bamet-D3.
    Martinez-Diez MC; Larena MG; Serrano MA; Macias RI; Izco-Basurko I; Marin JJ
    Anticancer Res; 2000; 20(5A):3315-21. PubMed ID: 11062759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
    Monte MJ; Ballestero MR; Briz O; Perez MJ; Marin JJ
    J Pharmacol Exp Ther; 2005 Oct; 315(1):24-35. PubMed ID: 15985617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming cisplatin resistance in vitro by a free and liposome-encapsulated bile acid derivative: BAMET-R2.
    Briz O; Serrano MA; Macias RI; Marin JJ
    Int J Cancer; 2000 Oct; 88(2):287-92. PubMed ID: 11004682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid secretion during rat liver carcinogenesis.
    Monte MJ; Palomero F; Sainz GR; Domínguez M; Díez M; Toraño A; Marin JJ
    Life Sci; 2000 Feb; 66(12):1085-95. PubMed ID: 10737359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity.
    Criado JJ; Herrera MC; Palomero MF; Medarde M; Rodriguez E; Marin JJ
    J Lipid Res; 1997 May; 38(5):1022-32. PubMed ID: 9186919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro test to determine the effect of cytostatic drugs on co-cultured rat hepatocytes and hepatoma cells.
    El-Mir MY; Serrano MA; Macias RI; Dominguez MF; Monte MJ; Marin JJ
    Int J Exp Pathol; 1998 Apr; 79(2):109-15. PubMed ID: 9709380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).
    Lozano E; Monte MJ; Briz O; Hernández-Hernández A; Banales JM; Marin JJ; Macias RI
    J Control Release; 2015 Oct; 216():93-102. PubMed ID: 26278512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.